Skip to main content

Blood Bank

Molecular

Molecular genetics provides the underlying explanation for the blood group polymorphisms we observe serologically. By analyzing DNA, we can directly determine an individual’s genetic potential to express specific antigens, overcoming many limitations of traditional serology and allowing for more precise and comprehensive blood group analysis, ultimately contributing to safer transfusions

At its core, molecular genetics in blood banking focuses on how the sequence of nucleotides (A, T, C, G) in our DNA dictates the blood group antigens expressed on our cells

The Central Dogma Revisited

  • DNA: Contains the genetic code, organized into genes
  • Transcription: The DNA sequence of a gene is copied into messenger RNA (mRNA)
  • Translation: The mRNA sequence is read by ribosomes, which assemble amino acids into a specific protein
  • Protein/Enzyme Function: This resulting protein might be the blood group antigen itself, or it might be an enzyme (like a glycosyltransferase) that modifies a precursor substance on the cell surface to create the antigen

From DNA Sequence to Antigen

  • Codons: The mRNA sequence is read in groups of three bases called codons. Each codon specifies a particular amino acid (or a stop signal)
  • Amino Acid Sequence: The sequence of codons dictates the sequence of amino acids in the protein
  • Protein Structure & Function: The amino acid sequence determines how the protein folds into its 3D shape, which is critical for its function (e.g., enzymatic activity, structural integrity, or acting as an antigen recognized by antibodies)

Genetic Variations: The Source of Blood Group Polymorphism

The differences between blood group alleles (like A vs. B, or K vs. k) arise from variations in the DNA sequence of the corresponding genes. Common types include:

  • Single Nucleotide Polymorphisms (SNPs): The most common type. A change in a single DNA base pair at a specific locus (e.g., a G changes to an A)
    • Impact: Can change the codon, leading to a different amino acid in the protein (missense mutation), potentially altering antigen structure or enzyme activity. Can create a stop codon (nonsense mutation), leading to a shortened, often non-functional protein. Can occur in non-coding regions (promoters, introns) and affect how much protein is made or how mRNA is processed
  • Insertions/Deletions (Indels): Addition or removal of one or more DNA base pairs
    • Impact: If the number of bases inserted/deleted is not a multiple of three, it causes a frameshift mutation. This changes the entire downstream codon reading frame, usually leading to a completely different and often non-functional protein, frequently ending prematurely with a stop codon. Small in-frame indels (multiples of 3) might add or remove amino acids but preserve the rest of the protein sequence. Large deletions can remove entire exons or even the whole gene
  • Gene Rearrangements/Fusions: More complex changes where parts of different genes might swap places (recombination) or fuse together
    • Impact: Can create hybrid genes encoding novel proteins with altered antigenic properties. Important in systems like MNS (creating variant glycophorins) and Rh (creating partial D antigens)

How Genes Produce Antigens - Two Main Routes

  • Route 1: Direct Gene Product is the Antigen: The gene directly codes for a protein that is itself, or part of, the blood group antigen embedded in the red cell membrane. Changes (like SNPs) in the gene directly alter the antigen’s structure
    • Examples: Rh: (RhD and RhCE proteins), MNS (Glycophorin A and B proteins), Kell (Kell protein), Duffy (Duffy protein/DARC), Kidd (Kidd urea transporter protein)
  • Route 2: Gene Product is an Enzyme (Glycosyltransferase): The gene codes for an enzyme, typically a glycosyltransferase. This enzyme then adds specific sugar molecules onto precursor carbohydrate chains already present on the red cell surface (or on glycoproteins/glycolipids). The resulting sugar structure is the antigen
    • Examples: ABO, H, Lewis, P1PK, I. The difference between A and B antigens isn’t the protein backbone, but the specific sugar added by the A or B transferase enzyme. The O allele often results from a frameshift deletion producing a non-functional enzyme, so no extra sugar is added to the H antigen precursor

Molecular Basis Examples

  • ABO System
    • The ABO gene encodes a glycosyltransferase
    • The A allele and B allele differ by a few key SNPs, resulting in enzymes that add different sugars (N-acetylgalactosamine for A, D-galactose for B) to the H antigen precursor
    • The most common O allele (O01) has a single base deletion near the start, causing a frameshift and a non-functional enzyme. Other O alleles exist with different mutations
    • Subgroups like A2 result from SNPs that make the A-transferase slightly less efficient than the A1 enzyme
  • Rh System
    • Two highly homologous (similar) and closely linked genes: RHD and RHCE
    • RhD Positive: Have a functional RHD gene
    • RhD Negative: Most commonly caused by a complete deletion of the RHD gene (common in Caucasians). Other mechanisms include inactivating mutations or rearrangements within RHD (more common in individuals of African or Asian descent)
    • C/c and E/e Antigens: Determined by SNPs within the RHCE gene. For example, a single SNP determines C vs c expression (encoding serine vs proline at position 103), and another SNP largely determines E vs e (proline vs alanine at position 226)
    • Weak D/Partial D: Result from various RHD gene alterations: missense mutations (SNPs) changing amino acids (often affecting antigen density - Weak D, or antigen structure - Partial D), or gene rearrangements creating hybrid RHD-RHCE genes
  • Kell System
    • The KEL gene encodes the Kell glycoprotein
    • The major K (K1) vs. k (K2, Cellano) polymorphism is due to a single SNP (C to T) changing one amino acid (Threonine to Methionine)
  • Duffy System
    • The DARC gene encodes the Duffy Antigen Receptor for Chemokines (DARC protein), which carries the Fya and Fyb antigens
    • Fya vs. Fyb is determined by a single SNP changing an amino acid
    • The common Fy(a-b-) phenotype in individuals of African descent is usually caused by an SNP in the promoter region (GATA box) of the DARC gene. This SNP prevents transcription (making mRNA) only in red blood cell precursors, so the Duffy protein isn’t made on RBCs, but it is still present on other tissues
  • MNS System
    • Two linked genes, GYPA and GYPB, encoding Glycophorin A (GPA) and Glycophorin B (GPB) respectively
    • M/N antigens: Located on GPA. Determined by SNPs in GYPA causing amino acid changes at positions 1 and 5
    • S/s antigens: Located on GPB. Determined by a single SNP in GYPB causing an amino acid change at position 29
    • U antigen: High-prevalence antigen associated with GPB. U-negative individuals often have deletions or rearrangements involving the GYPB gene

Molecular Techniques in the Reference Lab

Understanding the molecular basis allows for DNA-based testing (genotyping):

  • PCR (Polymerase Chain Reaction): Amplifies specific DNA regions of interest
  • Methods based on PCR
    • SSP (Sequence-Specific Priming): Uses primers designed to only bind and amplify specific alleles
    • RFLP (Restriction Fragment Length Polymorphism): Uses restriction enzymes to cut DNA at specific sequences; different alleles may have different cutting patterns if the mutation affects a restriction site
    • Sequencing: Directly determines the exact nucleotide sequence of a gene segment
    • Bead Chip Arrays/Microarrays: Simultaneously test for numerous SNPs across multiple blood group genes using probes attached to beads or a chip

Why is Molecular Genetics Important in Blood Bank?

  • Resolving Serologic Problems: When routine antibody-antigen tests give unclear, weak, or conflicting results
  • Testing Recently Transfused Patients: Serology detects antigens on both patient and donor cells. Genotyping looks at the patient’s own DNA, unaffected by transfusion
  • Testing DAT Positive Patients: Strong positive DAT can interfere with serological typing, especially for weaker antigens. Genotyping is unaffected
  • Predicting Antigen Phenotype When Antisera Are Unavailable: Especially for rare antigens or when commercial antisera are weak/limited
  • Fetal Genotyping: Can determine fetal RhD type (and other antigens) from maternal plasma (using cell-free fetal DNA) or amniotic fluid to assess risk for Hemolytic Disease of the Fetus and Newborn (HDFN)
  • Screening Donors: Identifying donors negative for multiple antigens or with rare blood types needed for specific patients
  • Understanding Weak/Variant Phenotypes: Differentiating between weak D types that can safely receive D+ blood vs. partial D types that should receive D- blood